Search

everythinglearnresearchcommunity

for

Search:↓

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Tumid lupus erythematosus can cause non-scarring hair loss on the scalp and requires careful diagnosis.

Multiphoton microscopy can effectively distinguish between scarring and non-scarring alopecia.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

LC-OCT can help identify lupus-related scarring hair loss by spotting unique features.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Vitamin D deficiency is common in children with non-scarring alopecia, and managing it may help treatment.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Frontal fibrosing alopecia is increasingly affecting men, causing hair loss around the hairline and possibly other areas.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

Lupus can look like hair loss from alopecia areata but needs different treatment.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The article explains how to diagnose and manage certain types of scarring hair loss.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.